Miyawaki, M., Naoki, K., Yoda, S., Nakayama, S., Satomi, R., Sato, T., . . . Soejima, K. (2017). Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001). Mol Clin Oncol.
Chicago ZitierstilMiyawaki, Masayoshi, et al. "Erlotinib As Second- or Third-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer: Keio Lung Oncology Group Study 001 (KLOG001)." Mol Clin Oncol 2017.
MLA ZitierstilMiyawaki, Masayoshi, et al. "Erlotinib As Second- or Third-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer: Keio Lung Oncology Group Study 001 (KLOG001)." Mol Clin Oncol 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.